CANCER BUZZ PODCAST

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.

In this episode, Lindsey Greenleaf, JD, MBA, leader in federal and state policy at ADVI Health and Pam Traxel, senior VP of alliance development and philanthropy at American Cancer Society, Cancer Action Network, discuss the impact of policy updates.

Immunotherapy and targeted therapies have transformed the way patients are treated and allow more patients than ever before to survive stage IV diagnoses.

All health systems work with limited resources to some degree. The challenge faced across the globe is finding the best way to allocate those resources to help the patient population as much as possible.

UCSF Health’s Seeking Care Patient Experience Team introduced web self-scheduling to improve fragmented workflows and streamline the process of seeking care from a cancer specialist.

CANCERBUZZ speaks with Dr. Naoto Ueno about his NOC session titled The Hawaiʻi Cancer Consortium: An Equitable Clinical Trials Initiative.

CANCERBUZZ speaks with Melanie Grant about her NOC session titled Navigating Access and Equity: Providing the Answers That Matter.

CANCERBUZZ speaks with guests at the 2024 NOC Gala event about what they are looking for at the conference.

CANCERBUZZ speaks with Terry Keys about his NOC session titled Empowering Partnerships: Enhancing Cancer Research Through Patient Advocacy.

CANCERBUZZ speaks with ACCC President Dr. Nadine Barrett about this year’s NOC theme: Realizing Innovation. Listen to what’s new in conversations and oncology education in 2024.

CANCERBUZZ speaks with ACCC’s Immediate Past President Dr. Olalekan Ajayi about the international panel held at NOC this year, where cancer care providers from around the world share and learn from common challenges and best practices.

CANCERBUZZ speaks with Magbis Nunez Love about her NOC session titled Renacer: Culturally Tailored, Patient-Centered Survivorship Care Improves Access and Outcomes.

Discussions from the ACCC 50th AMCCBS held from February 28 to March 1, 2024, were used to develop the 2024 Trending Now in Cancer Care Part 1 and Part 2 reports.

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD about the role of biomarker testing in guiding treatment decisions and how evidence-based management of treatment-related adverse events can serve this patient population.

When developing a health equity playbook, cancer programs need to break down existing silos and ensure that all key players are involved in developing strategies and identifying how the cancer program is going to use this tool to improve care.

In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC about shared decision making in the management of relapsed or refractory mantle cell lymphoma.